Daniel Skovronsky - 05 Jun 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Justin Hunter For: Daniel Skovronsky
Issuer symbol: MYGN
Transactions as of: 05 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 06 Jun 2025, 16:04:18 UTC
Previous filing: 12 Feb 2025
Next filing: 12 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Skovronsky Daniel	Director	322 NORTH 2200 WEST, SALT LAKE CITY	By: Justin Hunter For: Daniel Skovronsky	06 Jun 2025	0001741474

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+49.8K	+57.9%	$0.00	136K	05 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Content

Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.